SeeThruEquity Issues Update on Youngevity International, Increases Price Target to $0.61 Per Share

NEW YORK, NY / ACCESSWIRE / April 23, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a FY14 update on Youngevity International, Inc. (OTCQX: YGYI), a fast-growing, innovative, multi-dimensional company that is a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels.

The update note is available here: YGYI FY14 Update. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will also be available on these platforms.

Ajay Tandon, CEO of SeeThruEquity commented, “Given the strong growth evidenced ahead of our model in 2014, and our expectations for continued growth in 2015E, we are increasing our price target to $0.61 for Youngevity. Our 2015E estimates call for revenue of $177.8mn and EBITDA of $8.6, with EPS of $0.01. If achieved the target would potentially represent 142.9% potential upside from the recent market price of $0.25.”

Additional highlights of the update note are as follows:

Robust revenue growth to end in 2014

Youngevity demonstrated robust revenue growth in 2014 with topline results that grew 56.5% from 2013 and exceeded our estimates. The company turned in revenue of $134mn, with impressive growth across the board. The Direct Selling segment grew 51% YoY to reach $116.4mn, while the Commercial Coffee segment more than doubled from 2013 levels, at $17.7mn.

Profitability continues with EPS of $0.01

We were pleased to see Youngevity report net earnings ahead of our model, with GAAP EPS of $0.01, flat versus 2013 and better than our estimate of $0.00. Results benefitted from a tax benefit, but overall the management team appeared to do a good job balancing investments in growth with striving to achieve financial returns. Youngevity generated $1.9mn in cash from operating activities during 2014, and ended the year with cash on hand of $3.0mn.

International expansion to drive growth in 2015

Youngevity has demonstrated robust growth with a nice mixture of organic efforts as well as acquisitions. We look for the company to continue its growth trajectory in 2015 by making strategic acquisitions and expanding its geographic presence. 94% of revenues originated in the United States during 2014, though with products now sold in 70 countries and territories, we expect international sales to be a greater part of the whole in the future. At the end of 2014 Youngevity had operations in the United States and New Zealand, and had subsidiaries in Australia, New Zealand, Russia, Mexico, Israel, Nicaragua and Colombia. We expect continued international expansion throughout 2015. Indeed, so far the company has announced new international expansions in Kazakhstan and Singapore, and appointed a new Country Manager for Canada, which is its largest foreign market measured by revenue at this time.

Please review important disclosures on our website at www.seethruequity.com.

About Youngevity International, Inc.

Youngevity International Inc., (YGYI) (www.YGYI.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. The Company was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011. Formerly known as AL International, Inc., the Company changed its name to Youngevity International, Inc. in July 2013.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. We do not conduct any investment banking or commission based business. We are approved to contribute our research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distribute our research to our database of opt-in investors. We also contribute our estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 428122